Member Exclusive News

The week in industry: Collaboration launched to develop inhibitor for novel oncology target

This week: Avacta Group (Cambridge, UK) selects their clinical candidate from their Affimer Platform, the FDA grants accelerated approval of Genentech’s (CA, USA) treatment for patients with B-cell lymphoma and partnership announced to give UK SMEs access to novel mass spectrometry technologies.

Thumb untitled design
Jun 13, 2019
0
0

Please sign in or register for FREE

No comments yet.